Saturday, September 5, 2015| Latest E-book
You are here:
Sanofi-Aventis
#

Sanofi-Aventis

Articles

India Inc strikes deals worth nearly $27 bn in last 11 months

Dec 11, 2013

India Inc strikes deals worth nearly $27 bn in last 11 months

According to assurance, tax and advisory firm Grant Thornton, corporates in the country announced 458 deals in the January-November period amounting to USD 26.76 billion. #didyouknow #Sanofi-Aventis #Grant Thornton #Lodha Group #McDonald House
Shantha Biotech buyout: Sanofi to pay tax in France not India

Feb 16, 2013

Shantha Biotech buyout: Sanofi to pay tax in France not India

The Andhra Pradesh High Court today ruled that French drug maker Sanofi Aventis will not have to pay taxes in India for its buyout of Hyderabad-based vaccine firm Shantha Biotechnics in 2009. #NewsTracker #Sanofi-Aventis #Double taxation #Income tax #Shantha Biotech
Lupin gets USFDA approval for hypertension pills

Oct 17, 2012

Lupin gets USFDA approval for hypertension pills

Pharma major Lupin Wednesday said it has got approval from the US Food and Drugs Administration (FDA) to market generic versions of Sanofi Aventis' Avapro tablets, prescribed in the treatment of hypertension and nephropathy in Type-II diabetis. #Sanofi-Aventis #CompanyWatch #Lupin #Hypertension #USFDA
Dengue vaccine possible, though not any time soon

Sep 11, 2012

Dengue vaccine possible, though not any time soon

Inital trials of the dengue vaccine that were carried out in Thailand have been less than encouraging with only 30 percent efficacy and more research will be required. #NewsTracker #Sanofi-Aventis #Vaccine #Dengue fever #Thaliand
Cipla loses US court appeal over animal healthcare product

Jun 08, 2012

Cipla loses US court appeal over animal healthcare product

Pharmaceuticals major Cipla lost an appeal in the US court against Merial ltd, a subsidiary of Sanofi-Aventis for an animal healthcare product. Merial took Cipla to court saying the product infringed on a patent owned by Merial. #Health/Medical/Pharmaceuticals #Sanofi-Aventis S.A. #Cipla #CompanyWatch #Aventis #Cipla Ltd #Merial
Earnings blow fails to deter M&A flow for Corporate India

Aug 26, 2011

Earnings blow fails to deter M&A flow for Corporate India

The market too has nothing positive to offer. But the companies are high on inorganic growth and don't mind taking the bull by the horns. #Sanofi-Aventis S.A. #inthespotlight #Hotel Leela Venture Limited #NMDC Limited #Aventis Pharma Ltd
Sanofi deal creates buzz for Glenmark; re-rating likely

May 17, 2011

Sanofi deal creates buzz for Glenmark; re-rating likely

Macquarie finds Glenmark's valuation attractive and feels the market is not assigning any value to the company's innovation franchise because of a few setbacks in the past. #Health/Medical/Pharmaceuticals #NumberCrunching #Glenmark #Sanofi-Aventis #Macquarie Capital Securities Limited
Weak European markets and inflation data play spoilsport

May 16, 2011

Weak European markets and inflation data play spoilsport

Weak opening by European markets and higher than expected inflation numbers pull the markets down further. #BSE Sensex #Finance #EarlyTrend #Sanofi-Aventis S.A. #Glenmark Pharmaceuticals SA